Ensign Peak Advisors
ANGO icon

Ensign Peak Advisors’s AngioDynamics ANGO Stock Holding History

Ensign Peak Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,960
Closed -$306K – 1805
2022
Q3 		$306K Hold
14,960
– – ﹤0.01% 1701
2022
Q2 		$289K Hold
14,960
– – ﹤0.01% 1693
2022
Q1 		$322K Hold
14,960
– – ﹤0.01% 1726
2021
Q4 		$413K Sell
14,960
-940
-6% -$25.9K ﹤0.01% 1693
2021
Q3 		$412K Buy
15,900
+3,500
+28% +$93.6K ﹤0.01% 1661
2021
Q2 		$336K Hold
12,400
– – ﹤0.01% 1660
2021
Q1 		$290K Buy
12,400
+8,600
+226% +$174K ﹤0.01% 1683
2020
Q4 		$58K Buy
+3,800
New +$48.2K ﹤0.01% 1804

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's ANGO Position: Q4 2022 in Review

Ensign Peak Advisors sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 14,960 shares — an estimated $306K sold.

Ensign Peak Advisors first reported a position in ANGO in Q4 2020 and held it in 8 quarters. The position peaked at $413K in Q4 2021. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Ensign Peak Advisors reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 14,960 AngioDynamics shares in Q4 2022, an estimated $306K.
  • Ensign Peak Advisors first reported a position in AngioDynamics in Q4 2020 and held it in 8 quarters.
  • Ensign Peak Advisors's AngioDynamics position peaked at $413K in Q4 2021.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.